We aimed to evaluate the baseline characteristics, the reasons for prescription, and the effectiveness/safety profile of real-life apremilast for the treatment of psoriatic arthritis (PsA).
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients / E.G. Favalli, F. Conti, C. Selmi, F. Iannone, R. Bucci, F. D'Onofrio, G. Carlino, L. Santo, A. Semeraro, C. Zuccaro, S. D'Angelo, F. Atzeni, F. Marino, S. Monti, G.M. Guidelli, F.R. Spinelli, M. Biggioggero, R. Caporali. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 38:1(2020 Feb), pp. CER11692.19-CER11692.26.
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients
E.G. Favalli;C. Selmi;M. Biggioggero;R. Caporali
2020
Abstract
We aimed to evaluate the baseline characteristics, the reasons for prescription, and the effectiveness/safety profile of real-life apremilast for the treatment of psoriatic arthritis (PsA).Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.